share_log

維亞生物:就發行可轉換債券完成中國證監會發行後備案

VIVA BIOTECH: COMPLETION OF THE CSRC POST-ISSUE FILING IN RELATION TO THE ISSUE OF CONVERTIBLE BONDS

香港交易所 ·  Oct 25, 2023 06:50
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more